---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-25-000041"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2025-08-08T23:59:59+00:00"
generated_at: "2026-05-17T16:46:02.555781+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q2 revenue up 6.4% to $294M; Adj EBITDA +9.8% to $151M; raises FY outlook

## Summary
- Q2 net revenues $294M (+6.4% YoY); constant currency +6.0%; net income $8M ($0.03 diluted EPS).
- Adjusted EBITDA $151M (+9.8% YoY); Adjusted EPS $0.20 vs $0.19 prior year.
- Company raises full-year 2025 outlook: net revenue growth 4.5%-6.0%, Adj EBITDA growth 6.0%-7.5% constant currency.
- Net income impacted by $34M pending settlement related to ethylene oxide claims against Sterigenics.
- First-half 2025 net revenues $549M (+4.6% YoY); net loss $5M due to settlements totaling $65M.

## SEC filing metadata
- accession: 0001822479-25-000041
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2025-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/0001822479-25-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/shc-20250808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-25-000041
- JSON: https://secwatch.observer/filing/0001822479-25-000041.json
- Plain text: https://secwatch.observer/filing/0001822479-25-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.